Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The Inflation Reduction Act is unlikely to generate savings for taxpayers, while disrupting the market and creating perverse ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...

Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Two common natural nootropics are Bacopa Monnieri, known to support memory and reduce anxiety, and Rhodiola Rosea, reputed ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

Ohio congressman hopes to succeed current Energy and Commerce Chair Cathy McMorris Rodgers, who is retiring at the end of ...

lack of energy and diarrhea. Because early research shows many patients regain weight once they cease use of GLP-1, Bhatia ...

The yield has risen 73.6 basis points over the past seven weeks, according to Dow Jones Market Data. On Friday, traders were ...

Tánaiste Micheál Martin’s party launched its general election manifesto in the Smock Alley Theatre in Dublin on Monday ...